Betta Pharmaceuticals Co Ltd (300558) — Capital Reinvestment Ratio
Betta Pharmaceuticals Co Ltd (300558) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥224.45 Million) in capital expenditures (CN¥90.43 Million). See Betta Pharmaceuticals Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Betta Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Betta Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Check Betta Pharmaceuticals Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see market cap of Betta Pharmaceuticals Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥911.26 Million | CN¥616.68 Million | ▼ -25.5% |
| 2024 | 0.91x | CN¥911.17 Million | CN¥827.59 Million | ▼ -24.2% |
| 2023 | 1.20x | CN¥914.23 Million | CN¥1.10 Billion | ▼ -63.6% |
| 2022 | 3.29x | CN¥306.74 Million | CN¥1.01 Billion | ▲ +128.8% |
| 2021 | 1.44x | CN¥526.63 Million | CN¥758.38 Million | ▲ +35.6% |
| 2020 | 1.06x | CN¥646.02 Million | CN¥685.84 Million | ▼ -5.0% |
| 2019 | 1.12x | CN¥555.07 Million | CN¥620.42 Million | ▼ -47.9% |
| 2018 | 2.15x | CN¥286.40 Million | CN¥614.83 Million | ▲ +2.0% |
| 2017 | 2.11x | CN¥278.26 Million | CN¥585.78 Million | ▲ +191.0% |
| 2016 | 0.72x | CN¥407.05 Million | CN¥294.50 Million | ▲ +108.8% |
| 2015 | 0.35x | CN¥385.56 Million | CN¥133.60 Million | ▼ -43.3% |
| 2014 | 0.61x | CN¥277.55 Million | CN¥169.73 Million | ▲ +408.2% |
| 2013 | 0.12x | CN¥190.34 Million | CN¥22.90 Million | ▼ -54.0% |
| 2012 | 0.26x | CN¥149.29 Million | CN¥39.05 Million | ▼ -82.1% |
| 2011 | 1.46x | CN¥34.80 Million | CN¥50.81 Million | — |